One case of pharmaceutical care of drug exposure during pregnancy

doi:10.19803/j.1672-8629.20220626

Abstract

Abstract: Objective To explore the characteristics of drug exposure during pregnancy and the risks of drug use during pregnancy, and to study the methods and procedures of pharmaceutical care. Methods The outpatient pharmaceutical care for one case of periconceptional drug exposure was used to analyze the possible impact of exposure to such risk drugs as quinolones during pregnancy, and to evaluate the risk of medication for allergic rhinitis during pregnancy. Results The information was collected through pharmacy consultation, and the risk of medication was analyzed individually with high-level evidence. The pharmacist recommended that the patient continue pregnancy and receive related ultrasound examination. The pharmacist also evaluated the treatment plan according to the patient's conditions and gave advice on treatment of allergic rhinitis. Conclusion Pharmacists can play an important role in evaluating the risk of drug exposure during perinatal pregnancy, and provide more individualized pharmaceutical care for patients.

Key words: pregnancy, drug exposure, allergic rhinitis, risk assessment of medication, moxifloxacin, pharmaceutical care

CLC Number:

R969.4

WANG Ran, LI Yifan, LIU Xiaoyan, FENG Xin. One case of pharmaceutical care of drug exposure during pregnancy[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 933-934.

References

[1] HUANG H, LI XS, ZHANG J.Analysis of 8408 cases of outpatient medication consultation during pregnancy[J]. Evaluation and Analysis of Drug-Use in Hospitals of China(中国医院用药评价与分析), 2021, 21(5): 616-619.
[2] YI D, ZHANG J, HUANG L.Prescriptions for pregnant outpatients[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(8): 518-522.
[3] QIAO J, WANG YY, LI XH, et al.A lancet commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China[J]. Lancet, 2021, 397(10293): 2497-2536.
[4] ZHANG J, UNG C, GUAN X, et al.Safety of medication use during pregnancy in mainland China: based on a national health insurance database in 2015[J]. BMC Pregnancy and Childbirth, 2019, 19(1): 459.
[5] HAAS DM, MARSH DJ, DANG DT, et al.Prescription and other medication use in pregnancy[J]. Obstet Gynecol, 2018, 131(5): 789-798.
[6] HOUBEN E, WINKEL BT, STEEGERS EAP, et al.Dutch trends in the use of potentially harmful medication during pregnancy[J]. Br J Clin Pharmacol, 2020, 86(12): 2377-2392.
[7] GAI D, FENG X.New model of pharmaceutical care in drug safety of pregnant women[J]. Practical Pharmacy and Clinical Remedies(实用药物与临床), 2019, 22(11):1121-1124.
[8] TAO J, LI XH, TAN X, et al.Technical specification for consultation on the risk of drug teratogenicity during pregnancy[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics (Electronic Edition)(中华妇幼临床医学杂志电子版), 2021, 17(4): 393-401.
[9] YUAN M, ZHANG B.Research progress on pregnancy outcomes and related mechanisms of misuse of quinolones in early pregnancy[J]. Chinese Journal of Clinical Pharmacy(中国临床药学杂志), 2021, 30(2) :157-160.
[10] ACAR S, KESKIN-ARSLAN E, EROL-COSKUN H, et al.Pregnancy outcomes following quinolone and fluoroquinolone exposure during pregnancy: a systematic review and meta-analysis[J]. Reproductive Toxicology, 2019, 85: 65-74.
[11] ZIV A, MASARWA R, PERLMAN A, et al.Pregnancy outcomes following exposure to quinolone antibiotics - a systematic-review and meta-analysis[J]. Pharm Res, 2018, 35(5): 109.
[12] SCHAEFER C, PETERS P, MILLER RK.Pregnancy and lactation: treatment options and risk assessment[M]. Pittsburgh: Academic Press, 2015.
[13] BRIGGS GG, TOWERS CV, FORINASH AB.Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk[M]. 12th ed. Philadelphia : Lippincott Williams& Wilkins(LWW), 2021.
[14] SHEEHY O, SANTOS F, FERREIRA E, et al.The use of metronidazole during pregnancy: a review of evidence[J]. Curr Drug Saf, 2015, 10(2):170-179.
[15] QIN B.Investigation on the safety of metronidazole in pregnant women[D]. Chengdu: University of Electronic Science and Technology of China, 2020.
[16] WORKOWSKI KA, BACHMANN LH, CHAN PA, et al.Sexually transmitted infections treatment guidelines, 2021[J]. MMWR Recomm Rep, 2021, 70(4): 1-187.
[17] BERARD A, SHEEHY O, KURZINGER ML, et al.Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes[J]. J Allergy Clin Immunol 2016, 138(1): 96-97.
[18] NAMAZY JA, SCHATZ M.The safety of intranasal steroids during pregnancy: a good start[J]. J Allergy Clin Immunol, 2016, 138(1): 105-106.
[19] Subspecialty Group of Rhinology, Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery, Subspecialty Group of Rhinology, Society of Otorhinolaryngology Head and Neck Surgery,Chinese Medical Association. Chinese guideline for diagnosis and treatment of allergic rhinitis (2022, revision)[J]. Chin J Otorhinolaryngol Head Neck Surg(中华耳鼻咽喉头颈外科杂志), 2022, 57(2): 106-129.
[20] CHARLTON RA, SBOWBALL JM, NIGHTINGALE AL, et al. Sagety of fluticasone propionate prescribed for asthma during pregnancy: a UK population-based cohort study[J]. J Allergy Clin Immunol Pract, 2015, 3(5): 772-779. e3.